Skip to main content
Erschienen in: Journal of Neurology 10/2017

30.08.2017 | Original Communication

A specific pattern of gray matter atrophy in Alzheimer’s disease with depression

verfasst von: Efstratios Karavasilis, Theodore P. Parthimos, John D. Papatriantafyllou, Sokratis G. Papageorgiou, George Kapsas, Andrew C. Papanicolaou, Ioannis Seimenis

Erschienen in: Journal of Neurology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Considering the high incidence of depressive symptoms in Alzheimer’s disease (AD), we conducted a large-sample study to investigate the pattern of gray matter (GM) abnormalities that differentiates depressive from non-depressive AD patients. We included 201 AD patients who underwent MRI assessment and categorized them into depressive and non-depressive subgroups based on the Geriatric Depression Scale (GDS; cut-off score: ≤9). We performed whole-brain voxel-based morphometry analysis in 173 patients after MRI quality control and used between-group comparisons and regression analysis models to analyze the volumetric data controlling for nuisance variables. Depressive AD patients had extensive GM volume loss mainly in the paracentral region, specifically in post- and pre-central gyrus, supplementary motor areas and thalamus compared to non-depressive patients. Similar findings were obtained for the group of 173 patients using regression analysis and GDS score as predictor variable. We provided the first clear demonstration of a unique pattern of GM atrophy that characterizes AD patients with depression which is consistent with regions implicated in the phenomenon of psychomotor retardation that characterizes depression.
Literatur
1.
Zurück zum Zitat Lyketsos CG, Olin J (2002) Depression in Alzheimer’s disease: overview and treatment. Biol Psychiatry 52:243–252CrossRefPubMed Lyketsos CG, Olin J (2002) Depression in Alzheimer’s disease: overview and treatment. Biol Psychiatry 52:243–252CrossRefPubMed
2.
Zurück zum Zitat Modrego PJ (2010) Depression in Alzheimer’s disease pathophysiology, diagnosis, and treatment. J Alzheimers Dis 21:1077–1087CrossRefPubMed Modrego PJ (2010) Depression in Alzheimer’s disease pathophysiology, diagnosis, and treatment. J Alzheimers Dis 21:1077–1087CrossRefPubMed
3.
Zurück zum Zitat Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Xu W, Li JQ, Wang J, Lai TJ, Yu JT (2016) The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord 190:264–271CrossRefPubMed Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Xu W, Li JQ, Wang J, Lai TJ, Yu JT (2016) The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord 190:264–271CrossRefPubMed
4.
Zurück zum Zitat Logsdon RG, Gibbons LE, McCurry SM, Teri L (1999) Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging 5:21–32 Logsdon RG, Gibbons LE, McCurry SM, Teri L (1999) Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging 5:21–32
5.
Zurück zum Zitat Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 42:183–188CrossRefPubMed Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 42:183–188CrossRefPubMed
6.
Zurück zum Zitat Jack CR Jr, Petersen RC, Xu YC, Waring SC, O’Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49:786–794CrossRefPubMedPubMedCentral Jack CR Jr, Petersen RC, Xu YC, Waring SC, O’Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49:786–794CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neurostructural predictors of Alzheimer’s disease: a meta-analysis of VBM studies. Neurobiol Aging 32:1733–1741CrossRefPubMed Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neurostructural predictors of Alzheimer’s disease: a meta-analysis of VBM studies. Neurobiol Aging 32:1733–1741CrossRefPubMed
8.
Zurück zum Zitat Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN (1996) Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study. Brain 119:2001–2007CrossRefPubMed Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN (1996) Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study. Brain 119:2001–2007CrossRefPubMed
9.
Zurück zum Zitat Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358:201–205CrossRefPubMed Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358:201–205CrossRefPubMed
10.
Zurück zum Zitat Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer’s disease. Neurobiol Aging 33:e25–e36CrossRef Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer’s disease. Neurobiol Aging 33:e25–e36CrossRef
11.
Zurück zum Zitat Troisi A, Pasini A, Gori G, Sorbi T, Biagini A, Aulisi A, Baroni A, Ciani N (1992) Depression in Alzheimer’s disease: symptoms, syndrome, and computed tomography findings. Neurobiol Aging 13:S16 Troisi A, Pasini A, Gori G, Sorbi T, Biagini A, Aulisi A, Baroni A, Ciani N (1992) Depression in Alzheimer’s disease: symptoms, syndrome, and computed tomography findings. Neurobiol Aging 13:S16
12.
Zurück zum Zitat Son JH, Han DH, Min KJ, Kee BS (2013) Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer’s disease. Neurosci Lett 548:15–20CrossRefPubMed Son JH, Han DH, Min KJ, Kee BS (2013) Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer’s disease. Neurosci Lett 548:15–20CrossRefPubMed
13.
Zurück zum Zitat Boccia M, Acierno M, Piccardi L (2015) Neuroanatomy of Alzheimer’s disease and Late-life depression: a coordinate-based meta-analysis of MRI studies. J Alzheimers Dis 46:963–970CrossRefPubMed Boccia M, Acierno M, Piccardi L (2015) Neuroanatomy of Alzheimer’s disease and Late-life depression: a coordinate-based meta-analysis of MRI studies. J Alzheimers Dis 46:963–970CrossRefPubMed
14.
Zurück zum Zitat McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMedPubMedCentral McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Burke WJ, Nitcher RL, Roccaforte WH, Wengel SP (1992) A prospective evaluation of the Geriatric Depression Scale in an outpatient geriatric assessment center. J Am Geriatr Soc 40:1227–1230CrossRefPubMed Burke WJ, Nitcher RL, Roccaforte WH, Wengel SP (1992) A prospective evaluation of the Geriatric Depression Scale in an outpatient geriatric assessment center. J Am Geriatr Soc 40:1227–1230CrossRefPubMed
16.
Zurück zum Zitat Conradsson M, Rosendahl E, Littbrand H, Gustafson Y, Olofsson B, Lovheim H (2013) Usefulness of the Geriatric Depression Scale 15-item version among very old people with and without cognitive impairment. Aging Ment Health 17:638–645CrossRefPubMedPubMedCentral Conradsson M, Rosendahl E, Littbrand H, Gustafson Y, Olofsson B, Lovheim H (2013) Usefulness of the Geriatric Depression Scale 15-item version among very old people with and without cognitive impairment. Aging Ment Health 17:638–645CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat McGivney SA, Mulvihill M, Taylor B (1994) Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 42:490–492CrossRefPubMed McGivney SA, Mulvihill M, Taylor B (1994) Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 42:490–492CrossRefPubMed
18.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington
19.
Zurück zum Zitat Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, Leirer VO (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, Leirer VO (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef
21.
Zurück zum Zitat Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed
22.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRefPubMed Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRefPubMed
23.
Zurück zum Zitat Barnes J, Ridgway GR, Bartlett J, Henley SM, Lehmann M, Hobbs N, Clarkson MJ, MacManus DG, Ourselin S, Fox NC (2010) Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 53:1244–1255CrossRefPubMed Barnes J, Ridgway GR, Bartlett J, Henley SM, Lehmann M, Hobbs N, Clarkson MJ, MacManus DG, Ourselin S, Fox NC (2010) Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 53:1244–1255CrossRefPubMed
24.
Zurück zum Zitat Kostić VS, Agosta F, Petrović I, Galantucci S, Spica V, Jecmenica-Lukic M, Filippi M (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75:857–863CrossRefPubMed Kostić VS, Agosta F, Petrović I, Galantucci S, Spica V, Jecmenica-Lukic M, Filippi M (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75:857–863CrossRefPubMed
25.
Zurück zum Zitat Stonnington CM, Tan G, Klöppel S, Chu C, Draganski B, Jack CR Jr, Chen K, Ashburner J, Frackowiak RS (2008) Interpreting scan data acquired from multiple scanners: a study with Alzheimer’s disease. Neuroimage 39:1180–1185CrossRefPubMedPubMedCentral Stonnington CM, Tan G, Klöppel S, Chu C, Draganski B, Jack CR Jr, Chen K, Ashburner J, Frackowiak RS (2008) Interpreting scan data acquired from multiple scanners: a study with Alzheimer’s disease. Neuroimage 39:1180–1185CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Rzezak P, Squarzoni P, Duran FL, Alves TDTF, Tamashiro-Duran J, Bottino CM, Ribeiz S, Lotufo PA, Menezes PR, Scazufca M, Busatto GF (2015) Relationship between brain age-related reduction in gray matter and educational attainment. PLoS One 10(10):e0140945CrossRefPubMedPubMedCentral Rzezak P, Squarzoni P, Duran FL, Alves TDTF, Tamashiro-Duran J, Bottino CM, Ribeiz S, Lotufo PA, Menezes PR, Scazufca M, Busatto GF (2015) Relationship between brain age-related reduction in gray matter and educational attainment. PLoS One 10(10):e0140945CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Maldjian JA, Laurienti PJ, Burdette JB, Kraft RA (2003) An automated method for neuroanatomic and cytoarchitectonic atlas based interrogation of fMRI Data Sets. Neuroimage 19:1233–1239CrossRefPubMed Maldjian JA, Laurienti PJ, Burdette JB, Kraft RA (2003) An automated method for neuroanatomic and cytoarchitectonic atlas based interrogation of fMRI Data Sets. Neuroimage 19:1233–1239CrossRefPubMed
28.
Zurück zum Zitat Maldjian JA, Laurienti PJ, Burdette JH (2004) Precentral gyrus discrepancy in electronic versions of the Talairach Atlas. Neuroimage 21:450–455CrossRefPubMed Maldjian JA, Laurienti PJ, Burdette JH (2004) Precentral gyrus discrepancy in electronic versions of the Talairach Atlas. Neuroimage 21:450–455CrossRefPubMed
29.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289CrossRefPubMed Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289CrossRefPubMed
30.
Zurück zum Zitat Dubois B, Feldman HH, Jacova C, Hampel H, Molunuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629CrossRefPubMed Dubois B, Feldman HH, Jacova C, Hampel H, Molunuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629CrossRefPubMed
31.
Zurück zum Zitat Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRefPubMedPubMedCentral Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ, Members of the Alzheimer’s Disease Cooperative Study (ADCS) (2008) Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging 29:1285–1295CrossRefPubMed Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ, Members of the Alzheimer’s Disease Cooperative Study (ADCS) (2008) Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging 29:1285–1295CrossRefPubMed
33.
Zurück zum Zitat Rosano C, Bennett DA, Newman AB, Venkatraman V, Yaffe K, Harris T, Kritchevsky S, Aizenstein HJ (2012) Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults. J Gerontol A Biol Sci Med Sci 67:957–962CrossRefPubMedPubMedCentral Rosano C, Bennett DA, Newman AB, Venkatraman V, Yaffe K, Harris T, Kritchevsky S, Aizenstein HJ (2012) Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults. J Gerontol A Biol Sci Med Sci 67:957–962CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Ballmaier M, Kumar A, Thompson PM, Narr KL, Lavretsky H, Estanol L, Deluca H, Toga AW (2004) Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods. Am J Psychiatry 161:2091–2099CrossRefPubMed Ballmaier M, Kumar A, Thompson PM, Narr KL, Lavretsky H, Estanol L, Deluca H, Toga AW (2004) Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods. Am J Psychiatry 161:2091–2099CrossRefPubMed
35.
Zurück zum Zitat Canbeyli R (2010) Sensorimotor modulation of mood and depression: an integrative review. Behav Brain Res 207:249–264CrossRefPubMed Canbeyli R (2010) Sensorimotor modulation of mood and depression: an integrative review. Behav Brain Res 207:249–264CrossRefPubMed
36.
Zurück zum Zitat Zhang H, Li L, Wu M, Chen Z, Hu X, Chen Y, Zhu H, Jia Z, Gong Q (2016) Brain gray matter alterations in first episodes of depression: a meta-analysis of whole-brain studies. Neurosci Biobehav Rev 60:43–50CrossRefPubMed Zhang H, Li L, Wu M, Chen Z, Hu X, Chen Y, Zhu H, Jia Z, Gong Q (2016) Brain gray matter alterations in first episodes of depression: a meta-analysis of whole-brain studies. Neurosci Biobehav Rev 60:43–50CrossRefPubMed
37.
Zurück zum Zitat Leventhal AM, Rehm LP (2005) The empirical status of anhedonia: implications for psycology. Clin Psychol Rev 25:25–44CrossRefPubMed Leventhal AM, Rehm LP (2005) The empirical status of anhedonia: implications for psycology. Clin Psychol Rev 25:25–44CrossRefPubMed
38.
Zurück zum Zitat Schrijvers D, Hulstijin W, Sabbe BG (2008) Phychomotor symptoms in depression: a diagnostic pathophysiological and therapeutic tool. J Affect Disord 109:1–20CrossRefPubMed Schrijvers D, Hulstijin W, Sabbe BG (2008) Phychomotor symptoms in depression: a diagnostic pathophysiological and therapeutic tool. J Affect Disord 109:1–20CrossRefPubMed
39.
Zurück zum Zitat Exner C, Lange C, Irle E (2009) Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. J Affect Disord 119:156–162CrossRefPubMed Exner C, Lange C, Irle E (2009) Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. J Affect Disord 119:156–162CrossRefPubMed
40.
Zurück zum Zitat Guo Z, Liu X, Jia X, Hou H, Cao Y, Wei F, Li J, Chen X, Zhang Y, Shen Y, Wei L, Xu L, Chen W (2015) Regional coherence changes in Alzheimer’s disease patients with depressive symptoms: a resting-state functional MRI study. J Alzheimers Dis 48:603–611CrossRefPubMed Guo Z, Liu X, Jia X, Hou H, Cao Y, Wei F, Li J, Chen X, Zhang Y, Shen Y, Wei L, Xu L, Chen W (2015) Regional coherence changes in Alzheimer’s disease patients with depressive symptoms: a resting-state functional MRI study. J Alzheimers Dis 48:603–611CrossRefPubMed
41.
Zurück zum Zitat Krolak-Salmon P, Henaff MA, Vighetto A, Bauchet F, Bertrand O, Mauguiere F, Isnard J (2006) Experiencing and detecting happiness in humans: the role of the supplementary motor area. Ann Neurol 59:196–199CrossRefPubMed Krolak-Salmon P, Henaff MA, Vighetto A, Bauchet F, Bertrand O, Mauguiere F, Isnard J (2006) Experiencing and detecting happiness in humans: the role of the supplementary motor area. Ann Neurol 59:196–199CrossRefPubMed
42.
Zurück zum Zitat Guo Z, Liu X, Hou H, Wei F, Liu J, Chen X (2016) Abnormal degree centrality in Alzheimer’s disease patients with depression: a resting-state functional magnetic resonance imaging study. Exp Gerontol 79:61–66CrossRefPubMed Guo Z, Liu X, Hou H, Wei F, Liu J, Chen X (2016) Abnormal degree centrality in Alzheimer’s disease patients with depression: a resting-state functional magnetic resonance imaging study. Exp Gerontol 79:61–66CrossRefPubMed
43.
Zurück zum Zitat Buyukdura JS, McClintock SM, Croarkin PE (2011) Phychomotor retardation in depression: biological underpinnings, measurements, and treatment. Prog Neuropsychopharmacol Biol Psychiatry 35:395–409CrossRefPubMed Buyukdura JS, McClintock SM, Croarkin PE (2011) Phychomotor retardation in depression: biological underpinnings, measurements, and treatment. Prog Neuropsychopharmacol Biol Psychiatry 35:395–409CrossRefPubMed
44.
Zurück zum Zitat Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O’Brien JT, Scheltens Ph, McKeith IG, Williams D, Ballard C, Barkhof F (2003) A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. Neuroimage 18:895–907CrossRefPubMed Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O’Brien JT, Scheltens Ph, McKeith IG, Williams D, Ballard C, Barkhof F (2003) A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. Neuroimage 18:895–907CrossRefPubMed
45.
Zurück zum Zitat Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249:14–22CrossRefPubMed Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249:14–22CrossRefPubMed
46.
Zurück zum Zitat Blumberger DM, Hsu JH, Daskalakis ZJ (2016) A review of brain stimulation treatments for late-life depression. Curr Treat Options Psychiatry 2:413–421CrossRef Blumberger DM, Hsu JH, Daskalakis ZJ (2016) A review of brain stimulation treatments for late-life depression. Curr Treat Options Psychiatry 2:413–421CrossRef
47.
Zurück zum Zitat Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M, Marton RG, Rabey JM (2011) Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm (Vienna) 118:463–471CrossRef Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M, Marton RG, Rabey JM (2011) Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm (Vienna) 118:463–471CrossRef
48.
Zurück zum Zitat Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L (2015) Transcranial magnetic stimulation for geriatric depression: promises and pitfalls. World J Psychiatry 5:170–181PubMedPubMedCentral Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L (2015) Transcranial magnetic stimulation for geriatric depression: promises and pitfalls. World J Psychiatry 5:170–181PubMedPubMedCentral
49.
Zurück zum Zitat Fregni F, Santos CM, Myczkowski ML, Rigolino R, Gallucci-Neto J, Barbosa ER, Valente KD, Pascual-Leone A, Marcolin MA (2004) Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1171–1174CrossRefPubMedPubMedCentral Fregni F, Santos CM, Myczkowski ML, Rigolino R, Gallucci-Neto J, Barbosa ER, Valente KD, Pascual-Leone A, Marcolin MA (2004) Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1171–1174CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Elder GJ, Taylor JP (2014) Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? Alzheimers Res Ther 6:74CrossRefPubMedPubMedCentral Elder GJ, Taylor JP (2014) Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? Alzheimers Res Ther 6:74CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Wang WY, Yu JT, Liu Y, Yin RH, Wang HF, Wang J, Tan L, Radua J, Tan L (2015) Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease. Transl Neurodegener 4:6CrossRefPubMedPubMedCentral Wang WY, Yu JT, Liu Y, Yin RH, Wang HF, Wang J, Tan L, Radua J, Tan L (2015) Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease. Transl Neurodegener 4:6CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Konstantinopoulou E, Kosmidis MH, Ioannidis P, Kiosseoglou G, Karacostas D, Taskos N (2011) Adaptation of Addenbrooke’s cognitive examination-revised for the Greek population. Eur J Neurol 18:442–447CrossRefPubMed Konstantinopoulou E, Kosmidis MH, Ioannidis P, Kiosseoglou G, Karacostas D, Taskos N (2011) Adaptation of Addenbrooke’s cognitive examination-revised for the Greek population. Eur J Neurol 18:442–447CrossRefPubMed
53.
Zurück zum Zitat Ashtari M, Greenwald BS, Kramer-Ginsberg E, Hu J, Wu H, Patel M, Aupperle P, Pollack S (1999) Hippocampal/amygdala volumes in geriatric depression. Psychol Med 29:629–638CrossRefPubMed Ashtari M, Greenwald BS, Kramer-Ginsberg E, Hu J, Wu H, Patel M, Aupperle P, Pollack S (1999) Hippocampal/amygdala volumes in geriatric depression. Psychol Med 29:629–638CrossRefPubMed
54.
Zurück zum Zitat Avila R, Ribeiz S, Duran FL, Arrais JP, Moscoso MA, Bezerra DM, Jaluul O, Castro CC, Busatto GF, Bottino CM (2011) Effect of temporal lobe structure volume on memory in elderly depressed patients. Neurobiol Aging 32:1857–1867CrossRefPubMed Avila R, Ribeiz S, Duran FL, Arrais JP, Moscoso MA, Bezerra DM, Jaluul O, Castro CC, Busatto GF, Bottino CM (2011) Effect of temporal lobe structure volume on memory in elderly depressed patients. Neurobiol Aging 32:1857–1867CrossRefPubMed
55.
Zurück zum Zitat Janssen J, Hulshoff Pol HE, Schnack HG, Kok RM, Lampe IK, de Leeuw FE, Kahn RS, Heeren TJ (2007) Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatry 22:468–474CrossRefPubMed Janssen J, Hulshoff Pol HE, Schnack HG, Kok RM, Lampe IK, de Leeuw FE, Kahn RS, Heeren TJ (2007) Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatry 22:468–474CrossRefPubMed
56.
Zurück zum Zitat Sexton CE, Le Masurier M, Allan CL, Jenkinson M, McDermott L, Kalu UG, Herrmann LL, Bradley KM, Mackay CE, Ebmeier KP (2012) Magnetic resonance imaging in late-life depression: vascular and glucocorticoid cascade hypotheses. Br J Psychiatry 201:46–51CrossRefPubMed Sexton CE, Le Masurier M, Allan CL, Jenkinson M, McDermott L, Kalu UG, Herrmann LL, Bradley KM, Mackay CE, Ebmeier KP (2012) Magnetic resonance imaging in late-life depression: vascular and glucocorticoid cascade hypotheses. Br J Psychiatry 201:46–51CrossRefPubMed
57.
Zurück zum Zitat Goto M, Abe O, Aoki S, Hayashi N, Miyati T, Takao H, Iwatsubo T, Yamashita F, Matsuda H, Mori H, Kunimatsu A, Ino K, Yano K, Ohtomo K, Japanese Alzheimer’s Disease Neuroimaging Initiative (2013) Diffeomorphic anatomical registration through exponentiated lie algebra provides reduced effect of scanner for cortex volumetry with atlas-based method in healthy subjects. Neuroradiology 55:869–875CrossRefPubMed Goto M, Abe O, Aoki S, Hayashi N, Miyati T, Takao H, Iwatsubo T, Yamashita F, Matsuda H, Mori H, Kunimatsu A, Ino K, Yano K, Ohtomo K, Japanese Alzheimer’s Disease Neuroimaging Initiative (2013) Diffeomorphic anatomical registration through exponentiated lie algebra provides reduced effect of scanner for cortex volumetry with atlas-based method in healthy subjects. Neuroradiology 55:869–875CrossRefPubMed
58.
Zurück zum Zitat Roshchupkin GV, Adams HH, van der Lee SJ, Vernooij MW, van Duijn CM, Uitterlinden AG, van der Lugt A, Hofman A, Niessen WJ, Ikram MA (2016) Fine-mapping the effects of Alzheimer’s disease risk loci on brain morphology. Neurobiol Aging 48:204–211CrossRefPubMed Roshchupkin GV, Adams HH, van der Lee SJ, Vernooij MW, van Duijn CM, Uitterlinden AG, van der Lugt A, Hofman A, Niessen WJ, Ikram MA (2016) Fine-mapping the effects of Alzheimer’s disease risk loci on brain morphology. Neurobiol Aging 48:204–211CrossRefPubMed
59.
Zurück zum Zitat Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O (2016) Vascular depression consensus report—a critical update. BMC Med 14:161CrossRefPubMedPubMedCentral Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O (2016) Vascular depression consensus report—a critical update. BMC Med 14:161CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 26(341):366 Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 26(341):366
61.
Zurück zum Zitat Hoptman MJ, Gunning-Dixon FM, Murphy CF, Lim KO (2006) Alexopoulos GS Structural neuroimaging research methods in geriatric depression. Am J Geriatr Psychiatry 14:812–822CrossRefPubMedPubMedCentral Hoptman MJ, Gunning-Dixon FM, Murphy CF, Lim KO (2006) Alexopoulos GS Structural neuroimaging research methods in geriatric depression. Am J Geriatr Psychiatry 14:812–822CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Taylor WD, Aizenstein HJ, Alexopoulos GS (2013) The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18:963–974CrossRefPubMedPubMedCentral Taylor WD, Aizenstein HJ, Alexopoulos GS (2013) The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18:963–974CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Bates E, Wilson SM, Saygin AP (2003) Voxel-based lesion-symptom mapping. Nat Neurosci 6:448–450PubMed Bates E, Wilson SM, Saygin AP (2003) Voxel-based lesion-symptom mapping. Nat Neurosci 6:448–450PubMed
64.
Zurück zum Zitat Kim NY, Lee SC, Shin JC, Park JE, Kim YW (2016) Voxel-based lesion symptom mapping analysis of depressive mood in patients with isolated cerebellar stroke: a pilot study Neuroimage Clin 13:39–45PubMed Kim NY, Lee SC, Shin JC, Park JE, Kim YW (2016) Voxel-based lesion symptom mapping analysis of depressive mood in patients with isolated cerebellar stroke: a pilot study Neuroimage Clin 13:39–45PubMed
65.
Zurück zum Zitat Glasser MF, Smith SM, Marcus DS, Andersson JL, Auerbach EJ, Behrens TE, Coalson TS, Harms MP, Jenkinson M, Moeller S, Robinson EC, Sotiropoulos SN, Xu J, Yacoub E, Ugurbil K, Van Essen DC (2016) The human connectome project’s neuroimaging approach. Nat Neurosci 19:1175–1187CrossRefPubMed Glasser MF, Smith SM, Marcus DS, Andersson JL, Auerbach EJ, Behrens TE, Coalson TS, Harms MP, Jenkinson M, Moeller S, Robinson EC, Sotiropoulos SN, Xu J, Yacoub E, Ugurbil K, Van Essen DC (2016) The human connectome project’s neuroimaging approach. Nat Neurosci 19:1175–1187CrossRefPubMed
Metadaten
Titel
A specific pattern of gray matter atrophy in Alzheimer’s disease with depression
verfasst von
Efstratios Karavasilis
Theodore P. Parthimos
John D. Papatriantafyllou
Sokratis G. Papageorgiou
George Kapsas
Andrew C. Papanicolaou
Ioannis Seimenis
Publikationsdatum
30.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8603-z

Weitere Artikel der Ausgabe 10/2017

Journal of Neurology 10/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.